Role of clinical, patient-reported outcome and medico-economic studies in the public hospital drug formulary decision-making process: results of a European survey-Reference-Cited by-同舟云学术

Role of clinical, patient-reported outcome and medico-economic studies in the public hospital drug formulary decision-making process: results of a European survey

Published:2005-02 Issue:2 Volume:71 Page:205-212
ISSN:0168-8510
Container-title:Health Policy
language:en
Short-container-title:Health Policy

Author:

Haslé-Pham Elodie,Arnould Benoit,Späth Hans-Martin,Follet Alain,Duru Gérard,Marquis Patrick

Publisher

Elsevier BV

Subject

Health Policy

Reference18 articles.

1. Will managed care work in Europe?;Mossalios;Pharmacoeconomics,1997

2. Rational pharmacotherapy in The Netherlands: formulary management in Dutch hospitals;Fjin;Pharmacy World & Science,1999

3. Differences in attitudes, knowledge and use of economic evaluations in decision-making in the Netherlands. The Dutch results from the EUROMET project;Zwart-van Rijkom;Pharmacoeconomics,2000

4. The expanding role of pharmacy and therapeutics committees;Wade;Pharmacoeconomics,1996

5. Enquête sur le concept de comité du médicament;Ballereau;Revue de Pharmacie Hospitalière Franc̨aise,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries;International Journal of Environmental Research and Public Health;2022-06-27

2. Drug and therapeutics committees in Jordanian hospitals: a nation-wide survey of organization, activities, and drug selection procedures;Pharmacy Practice;2019-12-31

3. Managing conflicts of interest in pharmacy and therapeutics committees: A proposal for multicentre formulary development;Journal of Clinical Pharmacy and Therapeutics;2019-10-27

4. Applying an Implementation Framework to the Use of Evidence from Economic Evaluations in Making Healthcare Decisions;Applied Health Economics and Health Policy;2019-05-03

5. The evolution of the cancer formulary review in Canada: Can centralization improve the use of economic evaluation?;The International Journal of Health Planning and Management;2016-07-29